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Translating knowledge for action against
stroke – using 5-minute videos for stroke
survivors and caregivers to improve poststroke outcomes: study protocol for a
randomized controlled trial (Movies4Stroke)
Ayeesha Kamran Kamal1*, Adeel Khoja2, Bushra Usmani3, Abdul Muqeet4, Fabiha Zaidi4, Masood Ahmed5,
Saadia Shakeel5, Nabila Soomro6, Ambreen Gowani7, Nargis Asad8, Asma Ahmed9, Saleem Sayani10,
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Abstract
Background: Two thirds of the global mortality of stroke is borne by low and middle income countries (LMICs). Pakistan
is the world’s sixth most populous country with a stroke-vulnerable population and is without a single dedicated chronic
care center. In order to provide evidence for a viable solution responsive to this health care gap, and leveraging the
existing >70 % mobile phone density, we thought it rational to test the effectiveness of a mobile phone-based video
intervention of short 5-minute movies to educate and support stroke survivors and their primary caregivers.
Methods: Movies4Stroke will be a randomized control, outcome assessor blinded, parallel group, single center
superiority trial. Participants with an acute stroke, medically stable, with mild to moderate disability and having a
stable primary caregiver will be included. After obtaining informed consent the stroke survivor-caregiver dyad will be
randomized. Intervention participants will have the movie program software installed in their phone, desktop, or
Android device which will allow them to receive, view and repeat 5-minute videos on stroke-related topics at admission,
discharge and first and third months after enrollment. The control arm will receive standard of care at an internationally
accredited center with defined protocols. The primary outcome measure is medication adherence as ascertained by a
locally validated Morisky Medication Adherence Scale and control of major risk factors such as blood pressure, blood
sugar and blood cholesterol at 12 months post discharge. Secondary outcome measures are post-stroke complications
and mortality, caregiver knowledge and change in functional outcomes after acute stroke at 1, 3, 6, 9 and 12 months.
Movies4Stroke is designed to enroll 300 participant dyads after inflating 10 % to incorporate attrition and noncompliance and has been powered at 95 % to detect a 15 % difference between intervention and usual care arm.
Analysis will be done by the intention-to-treat principle.
Discussion: Movies4Stroke is a randomized trial testing an application aimed at supporting caregivers and stroke
survivors in a LMIC with no rehabilitation or chronic support systems.
Trial registration: NCT02202330 (28 January 2015)
Keywords: Stroke, Educational intervention, Behavior change, Mobile health, Implementation, Information and
communication technology, Prevention, Non-communicable disease, Low and middle income countries, Adherence
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Background
The World Health Organization (WHO) defines stroke as
“a focal (or at times global) neurological impairment of
sudden onset, and lasting more than 24 hours (or leading
to death) and of presumed vascular origin” [1]. Two
thirds, i.e., 36 million of the estimated 56 million deaths
worldwide are attributed to non-communicable diseases
(NCD), primarily stroke. Over 80 % of strokes now occur
in LMICs [2], with 15 million strokes occurring annually
worldwide, leaving five million dead, and five million permanently disabled. One person suffers a stroke every
45 seconds; one person dies of a stroke every 4 minutes
[3]. Globally, stroke accounts for 46.6 million disability adjusted life-years (DALYs) [4].
NCD and stroke are becoming an important issue in
Pakistan as the country undergoes demographic transition [5]. Pakistan, the sixth most populous nation in
the world, has a distinctively stroke-prone population.
Today, about one in four adult Pakistanis has hypertension and/or diabetes, heart disease, or a stroke equivalent [6]. Yet, early detection and risk reduction would
have prevented stroke in 80–90 % of victims [7]. A
local study conducted on one ethnicity (Pashtoon), reported a prevalence of 4.8 %, which would translate
into four million persons in a country of 180 million
[6]. In another hospital-based study, 65 % of adult Pakistani stroke survivors reported at least one post-stroke
complication and a 12 % mortality in the first year post
discharge [8].
This high-risk population is also highly underserved.
Health systems are acutely responsive and are not
equipped to respond to chronic diseases. There is not a
single inpatient comprehensive rehabilitation system.
Since the recent democratic reforms and 18th Constitutional Amendment, an opportunity has arisen for health
reform, where devolution has resulted in provincial autonomy for health [9]. Thus, evidence for a systematized,
replicable, scalable and effective response to chronic disorders is much more likely to be adapted.
In 80 % of stroke victims, further events may be prevented by altering lifestyle risk factors, and increasing
adherence to medications to control hypertension, diabetes and hyperlipidemia [10–12]. However, there exists
an implementation gap to adopt widely recognized beneficial medicines and lifestyle changes after stroke [6].
In this study, we will assess the effect of video-based
intervention on primary stroke survivors and their caregiver dyads on improving adherence to stroke preventive medications and control of three major risk factors
at 6 and 12 months in a Pakistani population. Our rationale is to leverage the existing mobile phone infrastructure and use IT to deliver post-stroke education to
dyads returning to the community and thereby improve
post-stroke outcomes. We hypothesize that there would
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be a difference of at least 15 % in adherence to stroke
preventive medications and control of three major risk
factors at 6 and 12 months among stroke survivors who
are given video-based education as compare to those
who are given usual care.
Study question

Does video-based intervention given to stroke survivors
(with mild to moderate disability) and their caregivers at
the time of enrollment into the study, at discharge and
sustained during follow-up, improve adherence to stroke
preventive medications and control of three major risk
factors (diabetes, hypertension and dyslipidemia) at 6
and 12 months after first ever stroke?
Primary objective

To determine the effect of video-based education intervention provided to patient and caregiver dyads after
first ever stroke on:
 Proportion of participants adhering to medications

prescribed (definition of adherence is the use of
prescribed medications on at least 5 days a week and
measured by the Morisky Medication Adherence
Scale)
 Proportion of participants achieving control of blood
pressure (control is defined as BP <125/85), blood
sugar (glycosylated hemoglobin (HbA1c) <7 %) and
blood cholesterol (low-density lipoprotein cholesterol
(LDL) <100 mg/dl)
Secondary objective

To determine the effect of video-based education intervention provided to patient and caregiver dyads after first ever
stroke on:
 Stroke-related knowledge assessment among









caregivers regarding risk factors, emergency
preparedness, stroke rehabilitation and medications
Readmission to hospital with any of the strokerelated complications – urinary tract infection,
pneumonia, and deep venous thrombosis, among
stroke survivors admitted to the AKUH Stroke Unit,
Karachi
Stroke-related mortality among stroke survivors
with mild to moderate disability admitted to the
AKUH Stroke Unit, Karachi
Change in functional outcome (severity and
disability after stroke) from baseline among stroke
survivors admitted to the AKUH Stroke Unit,
Karachi
Level of satisfaction with the intervention and
acceptability of mobile health (mHealth) innovations
by stroke survivor and caregiver dyads
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Methods
Study design

This will be a randomized controlled, outcome assessor blinded, parallel group, single center superiority
trial in which participants with first ever stroke (both
ischemic and hemorrhagic) will be randomized within
48 hours of their stroke to either the video-based education intervention group or the control group [13].
The video-based education intervention group will
have health education delivered through short videos
which will be shown to the participants and their caregivers at the time of admission, before discharge, and
follow-up at first and third month post discharge. The
control group will have standard care including predischarge education and counseling according to defined protocol. All participants enrolled in this video
education intervention group and control group will
be followed for 12 months post discharge for assessment of end-points (Refer to Fig. 1).
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including acute emergency care, appointments, and/or
follow-up visits.
Android mobile

Any portable telecommunication device based on the
Android Operating System, in the possession of either
the stroke survivor or the caregiver, which is compatible
with our Movies4Stroke Application.
Eligibility criteria
Inclusion criteria
 Adult men and women, 18 years of age or older
 Resident of Karachi and planning to live in Karachi

till the follow-up period
 Able to understand Urdu (language of the videos)
 Admitted with first ever stroke (ischemic or

hemorrhagic stroke)
 Modified Rankin score (mRS) ≤4 ( mild to moderate

stroke)
 Have at least one vascular risk factor that requires

Study setting

The trial will be conducted in the Stroke Unit, Neurology
ward at Aga Khan University Hospital (AKUH) Karachi,
Pakistan. AKUH is an internationally recognized tertiary
care institution certified by Joint Commission International Accreditation (JCIA) that caters to the needs of
large multi-ethnic urban population of 18 million.
Due to the high variability of stroke care being delivered in different centers of Karachi and the need to
evaluate a complex multimodal intervention against a
uniform standard of care, we chose to limit our study to
a single center. Usual care at AKUH involves a proper
stroke pathway which includes a standard protocol being followed by a neuro-physician, a stroke nurse, a
dietitian and a physiotherapist in accordance with institutional guidelines (please refer to Standard Care for
Stroke Survivors for details).
Population

The following criteria will be used while recruiting participants and caregivers throughout the study:
Stroke survivor

Any adult aged 18 years of age or older, having experienced first ever stroke (ischemic or hemorrhagic) within
the past 6 weeks, with mild to moderate disability.
Stroke is clinically stable and the stroke survivor is
returning to the community for chronic care.
Caregiver

An adult aged 18 years of age or older who is present
24 hours a day with the stroke survivor and provides
the overall day-to-day care of the stroke survivor,

medical intervention
 Consenting to participate in the study and follow-

up, both stroke survivor and caregiver
 Have a stable surrogate caregiver at home who is

responsible for appointments, follow-ups, overall care,
e.g., wife, daughters, daughter- in- law, husband
 Stroke is medically stable and participant is likely to
return to the community after the in- hospital stay
(thus, actively treated strokes, e.g., decompressive
surgeries, carotid endarterectomy (CEA), in-hospital
sepsis, ventilator complications) that essentially
preclude return to the community settings will not
be offered this chronic care support study
Exclusion criteria
 Serious aphasia, visual hemi-neglect, short-term

memory loss in the stroke survivor precluding
understanding, visualization or retention of the
video material (will be measured through the NIH
Stroke Scale performed by trained physicians; those
having a score of greater than 4 due to aphasia alone
will be excluded)
 Serious aphasia, visual hemi-neglect, short-term
memory loss, dementia in the caregiver precluding
understanding, visualization or retention of the
video material (will be measured through the NIH
Stroke Scale performed by trained physicians; those
having a score of greater than 4 due to aphasia alone
will be excluded, dementia status will be assessed by
the Mini-Mental State Examination)
 Iatrogenic stroke, i.e., stroke due to non-atherosclerotic
vascular disease and rare causes, e.g., carotid
dissections, gunshot wounds to the neck, post
coronary artery bypass grafting (CABG)
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Enrollment

Assessed for eligibility
Excluded (n = …)
Not meeting inclusion criteria
(n = …)
Refused to participate
(n = …)
Other reasons (n = …)

Informed Consent
Baseline Assessments:
Blood Pressure , FBS and LDL
Functional Outcomes (NIHSS, Barthel Index
& MRS)

Follow up

Allocation

Randomized (n = …)

Allocated to intervention
(n = …)

Allocated to Control
(n = …)

Standard Discharge Process
+5 minutes video

Standard Discharge
Process

Lost to follow up
(n = …) 1st, 3rd, 6th, 9th,
and 12th month of
discharge)

Lost to follow up
(n = …) 1st, 3rd, 6th,
9th, and 12th month of
discharge)

Follow-up Measurements
Primary
Medication Adherence (MMAS) Blood
Pressure, FBS and LDL

Additional Outcomes

Analysis

Stroke Knowledge Questionnaire
Functional Outcomes (NIHSS, Barthel
Index & MRS), Stroke related Mortality and
Complication

Analyzed (n = …)

Analyzed (n = …)

Excluded from analysis
(n = …)

Excluded from analysis
(n = …)

Fig. 1 Study flow chart

 Stroke survivor/Caregiver dyad continue post-stroke

care in a nursing assisted, professional or hospital setting
and do not return to the community after discharge

 Serious concurrent medical illnesses, like cancer,

renal failure, acute liver disease in past 6 months
(that precludes the use of statins), chronic liver
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disease that excludes the use of stroke preventive
medications, or require non-standardized therapy
 Use of any off-label, non-guideline medications
which, due to stroke survivors’ unique comorbidities, interfere with medication compliance
to antihypertensives, statins, antiplatelet agents and
diabetes control
Identification and enrollment of the study participants

Data collectors will screen the participants coming to
AKUH Stroke Unit, Neurology ward, Karachi. Data collectors will fill out the eligibility form and, if the participants
are found eligible for the study, they will be officially invited to participate in the trial. Informed consent will be
obtained from those participants who voluntarily wish to
be in our study. The study participants and their caregivers will be thoroughly counseled about the nature of
the study and required follow-up. It will also be explained
to study participants that the selection in the study group
is random. Stroke survivors will then undergo a detailed
interview regarding the socio-demographic, clinical and
functional assessment at baseline. Then, the participants
will undergo randomization to either the intervention
group or standard care group. After allocation assignment,
the research supervisor will thoroughly explain the details
of the software program and its installation and then
proceed with the delivery of the first set of 5- minute videos. Any questions pertaining to the use and the comprehension of the videos and software will be answered.
Videos will be shown at the time of enrollment into the
study, at discharge from the hospital, and follow-up at
first and third months post discharge and a memory

Fig. 2 Template for screenshot of short messaging service (SMS)
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card containing the Stroke4Movie Application will be
installed and programmed to deliver scheduled videos
on the participant’s Android phone. In case of the participant being allocated to the usual care group they
will be informed about the details regarding discharge
and the follow-up appointments at the clinic (Refer to
Fig. 2) (see Additional files 1, 2 and 3).
Sampling technique

A purposive sampling technique would be applied to select adult stroke survivors coming to the Stroke Unit,
Neurology ward, AKUH, Karachi after the assessment of
the eligibility criteria and informed consent. The purposive sampling technique is defined as the sample based
on researchers’ established criteria for eligibility. Access
to daily admission lists of stroke patients to all areas of
the hospital will serve as the reference sampling frame
for this exercise.
Randomization process

A computer-generated random number list will be used
to randomize subjects to the control arm or the intervention arm. The randomization center will be at a secure computer in the Clinical Trials Unit (CTU) and the
random number will be generated by the staff of the
CTU who are not involved in recruitment and/or outcome ascertainment.
Allocation concealment

Randomization sequence will not in any way be predictable as it will be centralized. No-one from the
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research team will have access to the randomization
sequence, block size, randomization envelopes or
code. Envelopes will be sealed, opaque and it will be
impossible to view the code even if it is held against
bright sunlight.
Sample size calculation

The study is designed to enroll 300 participant dyads
(150 participants and 150 caregivers in each group –
intervention versus standard care) after inflating 10 % to
incorporate attrition and non-compliance. The sample
size was calculated keeping in mind the two primary
end-points of medication adherence and risk factor control; the primary end-point that gave the highest sample
size was kept as the final sample size. This number of
participants would provide the study with the ability to
detect a 15 % difference among groups with a power of at
least 95 %. The proportion of participants achieving control of three modifiable risk factors (blood pressure, blood
cholesterol and blood sugar) was assumed to be 0.50 in
the treatment group and 0.350 in the control group. The
test statistics used was a two-sided Z test. The sample size
was calculated using NCSS PASS (version 2008).
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Multivariable analysis

A variable having a p value of less than or equal to 0.05
will be considered to be clinically significant as well as
statistically significant at the multivariable analysis level.
All variables that are considered to be significant at the
univariate analysis level will need to run through a stepwise model building approach (manual) to obtain a parsimonious model. Multiple linear regression (MLR) will
be used to predict the final model. Adjusted betacoefficients with their appropriate 95 % confidence interval will be reported for the final model. The final model
will be assessed for interaction between biologically
plausible variables as well as for confounding after
checking for interaction; beta-change (15 %) will be considered significant for confounding to be reported. Assessment of multicollinearity between two independent
variables will be carried out using appropriate statistical
tests. A correlation coefficient of more than 0.80 will be
treated as significant for multicollinearity. The model
will be assessed for the presence of outliers and influential observations and robust standard errors will be reported if influential observations are found.

Secondary end-points
Statistical analysis plan

Analysis will be performed on the basis of initial treatment allocation; that is the intention-to- treat (ITT)
principle.
Checking for normality and descriptive analysis

Histograms will be graphed to check the distribution of all
the continuous variables in the dataset. For descriptive
analysis, mean with standard deviation will be reported
for symmetrically distributed continuous variables while
median with interquartile range will be reported for not
symmetrically distributed continuous variables. For categorical data, frequency with percentages will be reported.
Univariate analysis

Scale examination of all the continuous variables will be
carried out. Some of the continuous variables will be
transformed into categories where needed. We might
need to collapse categories for categorical variables if we
have a sparse data problem. Multiple Linear Regression
(MLR) will be applied at the univariate analysis level.
Each variable will be regressed independently with the
primary end-point. Their assumptions will be checked
and their significance will be reported. At univariate analysis level, a variable will be considered to be biologically
significant as well as statistically significant if the p value
is less than or equal to 0.10. Crude beta-coefficient with
95 % confidence interval will also be reported.

To analyze the secondary outcome, caregivers’ mean
score of knowledge regarding stroke risk factors, stroke
rehabilitation and medications at each follow-up visit between the two groups will be calculated through Student’s T test if the outcome is symmetrically distributed
or the Mann-Whitney U test if the outcome is not symmetrically distributed.
The proportion of participants with respect to readmission to hospital with any of the stroke-related
complications between the two groups will be calculated
either by Pearson’s chi-square test or Fischer’s exact test
(if the expected cell count is less than 5).
The proportion of participants with respect to strokerelated mortality between the two groups will be calculated either by Pearson’s chi-square test or Fischer’s
exact test (if the expected cell count is less than 5).
The change in mean score of National Institutes of
Health Stroke Scale (NIHSS), Barthel Index and mRS from
baseline at each follow-up visit between the two groups,
will be calculated through Student’s T test if the outcome
is symmetrically distributed or the Mann-Whitney U test
if the outcome is not symmetrically distributed.
The change in mean scores for level of satisfaction
with the intervention and acceptability of mHealth
innovation at the third month follow-up visit post discharge between the two groups will be calculated
through Student’s T test if the outcome is symmetrically
distributed or the Mann-Whitney U test if the outcome
is not symmetrically distributed.
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Outcome assessment

The outcome assessment will be at 1, 3, 6, 9 and
12 months post discharge. Assessors will not be allowed
to view the cell phone of the participant and they will be
instructed not to ask participants the following question:
“Did you watch any videos on stroke?” They will be
trained to accept random quality cross checks. A random
cross check will be done of assessor quality by asking 30 %
of the participants if they were asked the above question
on assessments. Since our outcome assessment will be
blinded and, if an unblinding/protocol violation has occurred at the assessor level, the participant will be removed from the final analysis to avoid assessor bias that
may shift the outcome in favor of the intervention.
At an assessment visit:
1. A detailed questionnaire will be filled out which will
collect information on:
 Medication adherence
 History of hospitalizations since discharge, with
any of the stroke complications and associated
mortality
 Knowledge level of stroke survivor/caregiver
2. Stroke survivors will have blood pressure
measurement, two separate readings at least
10 minutes apart, at resting and in sitting positions
3. Participants will be asked to give blood samples for
serum cholesterol, fasting blood sugar and HbA1c
(if diabetic) at 6 and 12 months post discharge
Primary study outcomes

All participants will be assessed for outcomes at 1, 3, 6,
9 and 12 months post discharge. The two arms will be
compared with respect to:
1. Proportion of participants adhering to medications
prescribed (definition of adherence – use of
prescribed medications on at least 5 days a week and
measured by the locally validated Morisky
Medication Adherence Scale [14]
2. Proportion of participants achieving control of
blood pressure (control is defined as BP <125/85),
blood sugar (HbA1c <7 %) and blood cholesterol
(LDL <100 mg/dl) [14]
Secondary study outcomes

1. Change in knowledge of caregivers concerning
stroke risk factors, stroke rehabilitation and
medications (a knowledge questionnaire will
be administered at 1, 3, 6, 9 and 12 months
post discharge and change in score will be
ascertained)
2. Readmission to hospital with any of the strokerelated complications – urinary tract infection,
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pneumonia, and deep venous thrombosis (this
information will be elicited at the follow-up time,
based on recall. All participants will be asked to
bring documents related to any hospital admissions
in the period following discharge)
3. Stroke-related mortality will be assessed through a
Verbal Autopsy Scale adopted from the WHO [15]
4. Change in functional outcome (severity and
disability after stroke) from baseline among stroke
survivors will be assessed through validated tools
(NIHSS, Barthel Index and mRS) [16]
5. Level of satisfaction with the intervention and
acceptability of mHealth innovation such as videos
on selected topics among stroke survivors and
caregiver dyads to improve clinical outcomes. This
will be done on a self-designed tool which ascertains
the constructive and unpleasant attributes of using
this mHealth technology (please refer to Form C,
Data Collection Form for Stroke Survivors– see
Additional file 1). This self-designed tool will be
administered by a research supervisor who will be
unblinded to the randomization group. This tool
has design attributes based on Rogers’ Diffusion of
Innovation Theory for ease, adoption, repeatability,
and adaptability [17].
Intervention

Intervention consists of: 5-minute videos, on various stroke-related topics/
themes delivered at the time of enrollment into the
study, before discharge from the hospital, at first
and third month follow-up post discharge
 Session 1 will be delivered at the time of enrollment
into the study and will cover themes on information
for caregivers including recognition of stroke, and
different skills will be taught to the caregivers
including swallowing exercises, different
rehabilitation exercises and naso-gastric tube feeding
 Session 2 will be delivered at the time of discharge
from the hospital and will include videos on
emergency preparedness – cardiopulmonary
resuscitation, seizures, heart attack, hypoglycemia
and recurrent stroke
 Session 3 will be delivered at first month followup post discharge and will include videos on
frequently used medications by stroke survivors,
such as anticoagulant, antihypertensive and
lipid-lowering drugs
 Session 4 will be delivered at third month follow-up
post discharge and will include videos on secondary
stroke prevention (recurrent attack) – exercise,
physical activity, recognition of depression, diet
modification and accurate measurement of blood
pressure and blood sugar
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 Please refer to Additional file 4 (Video Thematic

Intervention Chart) which demonstrates the core
messages that will be delivered in the videos
 Discussion and question and answers after
viewing each set of videos to ensure that the
core message has been understood and there
are no lacunae in understanding the message
imparted by the videos, which may be re-wound
and re-run for those who could not understand a
particular message
 Movies4Stroke Application Installation in a memory
card – a memory card containing the movies
application will be installed in the participants’ cell
phones in the intervention group to ensure that the
videos can be replayed at home to refresh the
memory of various details which may not have been
captured in the mandatory viewing session that
captures the usage data
Compliance during the administration of intervention

The study officer, after receiving randomization to the
intervention group will perform the following functions:
 Ensure that there is space and time for both









caregiver and stroke survivor to feasibly watch the
videos and that both are receptive
Ensure that there is no contamination by delivering
the video in a non-public area – participant’s room
if private or semi-private, counseling room if a
general ward patient
Ensure that the sound quality is at a level that is
clear to both stroke survivor and caregiver and that
both are receptive
Ensure that the caregiver sees all the videos in the
tablet at least once as administered by the unblinded
study officer
Check if the videos can be replayed on the dyad’s
home Android systems and that there are no
technical issues

Video translation and adaptation

The science in the videos is based on class I A evidence
[18, 19]. However, the language of the instructions and
the setting will be tailored according to culturally accepted norms [20]. Specifically, we want local resonance
and acceptability [21]. Videos prior to being launched in
the field will be shown to laypersons, stroke survivors
and stroke caregivers to obtain feedback. Since this is a
digital media, editing the same is feasible. Those who
will assess the movie content in the pre-testing phase of
the intervention will not be recruited in this implementation study.
The 5-minute idea is to hold attention, offer repeatability and engender self-efficacy [20, 22]. There should
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be sense of empowerment with manageable information.
This is very important for cognitive, literacy and numeracy impaired populations [23]. For future scalability,
digital media that last for 8–10 minutes can take excessive space and time downloading which can lead to user
frustration and failure [24, 25]. Since these videos will be
a resource, they should tend to be user friendly across
platforms and systems, and time compression would
achieve that goal. A similar concept has also been utilized in medical education internationally [26].
Measuring adherence to video intervention

To ensure adherence to intervention in the video group,
at least one viewing will be delivered in the hospital or the
CTU through active involvement of stroke survivors and
their caregivers. In order to ensure that each important
learning point is made clear in the first session, the key
pre-test and post-test knowledge questions, which will be
embedded in the movie application software for each set
of movies, will form a template for testing and discussion.
Throughout the videos, both stroke survivors and their
caregivers will be encouraged to ask questions and clear
their queries with the respective team members, and questions and answers accompany each video to provide a
platform for discussion and comprehension. Since learning is enhanced by repetition, we will enable repeat viewing with a phone card memory application that contains
the relevant videos [27]. Thus, those who are too stressed
to learn in the first place, or who are older adult learners,
will have the ability to review the videos in addition to the
mandatory session. The Movies4Stroke Application Software (Refer to Fig. 3) will have the ability to monitor video
usage and views by the user. This will help us in calculating the ‘sticky time’ (time spent using and interacting with
the movie application software), the rationale being that
we will be able to track actual usage of our intervention in
the video arm in real time.
Standard of care for stroke survivors (control group)

Stroke survivors will be given instructions before discharge regarding diet, need for rehabilitation, possible
complications, and medication use and information
booklets will also be handed out. The information will
be imparted by a multidisciplinary team consisting of a
neuro-physician, a stroke nurse, a dietitian and a physiotherapist. There will also be verbal instructions given to
the stroke survivors and their caregivers. On the day of
discharge, or 24 hours prior to discharge, a discharge coordinator will give the details about the skills learnt and
will ensure that the medical, social, and rehabilitation requirements are in place prior to leaving hospital. All
acute stroke survivors will be given follow-up appointments at the clinic. A detailed written discharge summary will be given out to the caregiver detailing all

Kamal et al. Trials (2016) 17:52

Page 9 of 13

Fig. 3 User interface snapshots of the movie software

aspects of care, follow-up, medications, test results and
serious alerts. This standard of care will be followed for
all participants including those who receive video-based
intervention.

Operational plan
Pre-field activities

Hiring and training of staff Four experienced research
associates will be recruited for a total duration of
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12 months. One research supervisor will be recruited
full-time for a total duration of 15 months. The research
supervisor should at least possess an MBBS degree with
relevant experience in clinical neurology. All the members in the team including the research supervisor will
be given formal training in interviewing (data collection)
for at least 2 weeks.
Research training will emphasize on the following areas:
 Introduction of the Study Project and the concerned

team members
 Administration of the questionnaire and its







completeness including the quality control
procedures and compliance during the
administration of the intervention
Contact information and follow-up procedures
Emphasis on communication skills and how the data
collectors should communicate with the study
participants and their caregivers
Procedure pertaining to informed consent
Introduction to the video intervention and
technical aspects of the software

Pre-testing of the questionnaire

Pre-testing will be done on 20 % of the total sample size,
that is 60 participant dyads, and those participants will
be excluded from the final analysis. Questions that will
require some changes due to phrasing and improper
translation will be amended after pre-testing.
Instructions for follow-up

Each stroke survivor caregiver dyad will be required to
follow up at 1, 3, 6, 9 and 12 months post discharge in
the neurology clinic for outcome ascertainment. Stroke
survivors and their caregivers will be given a handout
which will have instructions and basic information about
their follow-up visits. Follow-up visit explanations will be
given verbally to caregivers together with emphasizing the
importance of their patient’s follow-up visit. They will be
asked to contact the study team through our Stroke Helpline for any queries that arise in the interim period.
Follow-up visits in the neurology clinic

Follow-up visits at 1, 3, 6, 9 and 12 months will be organized in the neurology outpatient clinic to assess outcome. In order to maximize our follow-up, participants
will be sent short messaging service (SMS) reminders
through our Stroke Helpline a day prior to the visit and
transport will be arranged to facilitate the visit. If a
stroke survivor along with their caregiver is not able to
report for follow-up on the exact date, a grace period of
±14 days will be permitted to ensure capturing maximum follow-up. Those participant dyads that cannot
appear for the follow-up in person will be contacted via
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phone or through establishing a follow-up visit appointment in synchrony with other clinical visits, physiotherapy sessions and laboratory investigations.
Data management
Data management plan

A data entry officer will work in conjunction with the
principal investigator (PI). The data entry officer will be
given a formal training session on how to read the filled
data forms and then enter it in the database. A codebook
that contains specific number codes for each item of the
questionnaire used in the data collection forms will be
introduced to the data entry officer. The PI will request
the data entry officer to enter the data for the five study
participants in front of the PI so that any mistakes or
discrepancies can be immediately rectified. A similar
quality cross check will be performed during the double
data entry process.
Data editing

Data editing will ensure a complete data file for each
participant. This will be done to check for any missing,
incomplete or incorrect information provided at the
time of interview by a stroke survivor or their caregiver.
The data collectors will edit the filled questionnaire on a
daily basis. Editing will be performed in two stages in
order to avoid missing or inappropriate information.
The field editing will be done by interviewers, just after
the data collection process so that missing information
can be obtained and any inappropriate information can
be corrected. In case of missing or inappropriate information, the PI will contact the participant on their cell/
home phone number for correction. Any missing information or discrepancies will be clarified immediately;
every effort will be made to complete the information.
The data will be double checked by a research supervisor and the PI on a weekly basis.
Data entry

The data entry program will be created in EpiData version
3.1. Data will be double entered by two independent data
entry operators. The two datasets will then be compared
for the consistency of data and for missing values. Correction will be made by referring to a particular question.
Data storage

Designated computers that are based at the CTU will
store the data. Only research staff will be authorized
entry into the system computers. All source documents
will be maintained in locked files in locked rooms in accordance with patient privacy and confidentiality. After
the study period is over, data will be stored for another
5 years as per institutional guidelines.
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Ethical considerations

Our study was approved by the Ethical Review Committee
of Aga Khan University (AKU), Karachi (ERC # 2890Med-ERC-14). Principles of autonomy, anonymity, confidentiality and equity will be followed throughout the
study. Importantly, all videos will be viewed privately. No
video or phone will have any icon that suggests that the
person has a disease. No phone information of individuals
will be made public even within the team; only coordinators or those with direct patient contact will have access
to this information.
All videos developed will be ultimately shared with all
participants as well as within the community so as to
maximize the benefit to people of the educational tool.
Any modifications or changes in the protocol shall be
communicated to the Ethical Review Committee and implemented after approval.
Informed consent procedures

All participants and their caregivers will provide informed consent. This will be sought via trained research
staff who will tell them exactly what time commitments
are being sought from them. We will document oral and
written consent to participation. Prior to testing we will
train all research personnel about informed consent procedures. All participants and their caregivers may choose
to withdraw at any time (see Additional file 5).
Informed consent will be taken separately from both
the stroke survivors and their caregivers who voluntarily
agree to participate in the study.
Dissemination

Dissemination through publications, research seminars,
conferences and mass media will be done. Free upload
and sharing of video education will be available at the
AKU website after due clearances are made with IT,
University Research Council (URC), the Research Office
and media group of AKUH.

Discussion
The overarching goal of this clinical trial is to test the
power of IT-based education using Android handsets as
vehicles for teaching post-stroke survival skills to stroke
survivors and caregiver dyads in a low and middle income country (LMIC) setting [28] (refer to Additional
file 6 for SPIRIT Checklist). Previous studies that have
used education to assist stroke survivors in communities
are mainly based in developed countries (see Additional
file 7).
A randomized controlled, single center, clinical trial
assessed the effect of training of caregivers of stroke participants in a stroke rehabilitation unit on discharge, at 3
and at 12 months [28]. This study showed a significant
difference between the trained group and conventional
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caregivers with respect to quality of life and mood outcomes, and burden of care, as well as cost-effectiveness.
Another multicenter study that enabled caregivers during inpatient hospitalization, recommended more
follow-up training after discharge due to lack of sustained effect [29, 30]. A Cochrane Review based on
caregiver enablement via non- pharmacological interventions listing eight studies with 1007 participants,
with heterogeneous follow-ups, interventions and settings, concluded that more work was needed in this area
due to heterogeneity of effect [31]. None of these interventions took into consideration resource-poor, healthilliterate populations, fragmented health systems, attention to scalability, or adaptation to local needs, or used
digital media.
The health care system in Pakistan represents a unique
challenge. Like other LMICs with rapid demographic transition, there is now a double burden of maternal and
childhood illnesses along with a significant additional
NCD burden [32]. However, the health systems are not
prepared for this challenge. There is not a single inpatient
rehabilitation center for stroke survivors and the majority
of care is provided directly by caregivers [5, 33, 34].
While there is a relative lag in development of such
centers, we plan to test and leverage our existing mobile
infrastructure as a means of providing continuous care.
Based on the current statistics by the Pakistan Telecommunication Authority, mobile phone users in Pakistan
were recorded to number greater than 137 million and
total cellular density had reached 77 % by 2014 [35]. In
addition, mobile brands have introduced cheap Android
Smart phones that are rapidly becoming mainstream
and are expected to take over the larger market share,
with the cheapest Smart phone starting from around
US$6 [25]. Thus, we developed this interactive Android
application.
mHealth applications have tremendous potential for
chronic disease support. However, these software applications have not been tested in rigorous trial designs
with clinically meaningful outcomes [36–38, 39].
The strength of this study is the use of a rigorous randomized controlled trial (RCT) design, measurement of
intervention usage and fidelity, intervention delivery
that is present both within the hospital and at followup, evaluation of clinically important outcomes and ITT
analysis [40].
The limitations include the following: selection bias: this
is a single center study chosen because of the fact that this
site provides a standard of care that is algorithmic and
replicable; thus, any results may be attributed to the intervention. In this study we may report its efficacy, but the
performance in different sites may vary; contamination
bias: in an educational intervention, care will have to be
taken to avoid contamination of the non-intervention arm
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with the intervention. To ensure this, videos will be shown
in a separate room, and not at the bedside. Given the fact
that families do share information, contamination is possible; however, most stroke participants are on different
schedules for visits, rehabilitation times, etc. and so we expect less contamination than in areas where a lot of time
is spent together by families; attrition bias: many participants may drop out due to the longitudinal nature of the
study. To counteract this, trained health care providers
will try to follow the subjects closely through regular
phone calls and build good rapport with them. A Stroke
Helpline number will also be provided.
If this initial study shows promising results, we will
plan a larger study where interactive chronic disease
support software will be evaluated for reduction in mortality and disability after acute stroke for families living
in LMIC settings.
Trial status

Ongoing
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